Breaking News

You are here » Indian-Commodity  :  Equity & Shares  :  Zensar Technologies gains on launching second Zenlabs at Hyderabad

17-May2018

Zensar Technologies gains on launching second Zenlabs at Hyderabad

Zensar Technologies is currently trading at Rs. 1236.15, up by 7.75 points or 0.63% from its previous closing of Rs. 1228.40 on the BSE.

The scrip opened at Rs. 1250.00 and has touched a high and low of Rs. 1255.00 and Rs. 1221.30 respectively. So far 322 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 1323.60 on 02-May-2018 and a 52 week low of Rs. 729.90 on 16-Feb-2018.

Last one week high and low of the scrip stood at Rs. 1275.00 and Rs. 1160.15 respectively. The current market cap of the company is Rs. 5562.73 crore.

The promoters holding in the company stood at 48.88%, while Institutions and Non-Institutions held 18.39% and 32.73% respectively.

Zensar Technologies has launched second innovation hub called 'Zenlabs' in Hyderabad, India. The first one is located in Pune, India. The key objective of the Zenlabs is to build customer focused solutions across next generation technologies like Artificial Intelligence (AI), Distributed Ledger Technologies / Blockchain, Internet of Things (loT), Augmented (AR) & Virtual Reality (VR). The new team at Hyderabad will work in close collaboration with the Pune team.

Zensar Technologies operates as a software service company. It is engaged in software development, networking, e-commerce, and systems integration services. It also provides consulting, collaboration services and business process outsourcing services.


Related News

View all news

IndiGo trades in green on the BSE

Interglobe Aviation (IndiGo) is currently trading at Rs. 1063.55, up by 20.35 points or 1.95% from its previous closing of Rs. 1043.20 on the BSE.The scrip opened at Rs. 1034.00 and has touched a high......

Shilpa Medicare surges on getting tentative ANDA approval for Dimethyl Fumarate DR Capsules

Shilpa Medicare is currently trading at Rs. 388.65, up by 14.65 points or 3.92% from its previous closing of Rs. 374.00 on the BSE.The scrip opened at Rs. 383.95 and has touched a high and low of Rs. 399.75......

Pfizer shines despite reporting 14% fall in Q2 net profit

Pfizer is currently trading at Rs. 2865.00, up by 86.25 points or 3.10% from its previous closing of Rs. 2778.75 on the BSE.The scrip opened at Rs. 2815.50 and has touched a high and low of Rs. 2866.80......

Top News

View all news

Karnataka Bank launches CASA campaign

Karnataka Bank has launched Current & Savings Accounts campaign (CASA) of FY 2018-19 and introduced a new SB scheme 'KBL SB - TASC' a specialized product for Trusts/Associates/Societies/Clubs.Under......

M&M's arm opens manufacturing hub in Bengaluru

Mahindra & Mahindra's (M&M) subsidiary -- Mahindra Electric Mobility has opened its electric technology manufacturing hub set up with an investment of Rs 100 crore in Bengaluru. The plant......

Venus Remedies reports positive result in Phase-3 Clinical Trials for ELORES

Venus Remedies has reported positive Top-Line results in its Phase-3 Clinical Trials for its flagship product ELORES. The results were presented at IDWeek 2018 in San Francisco. IDWeek is an annual scientific......